July 23 (Reuters) - Medicover AB MCOVb.ST :
* INTERIM REPORT APRIL-JUNE 2021
* Q2 REVENUE AMOUNTED TO EUR 348.9M (EUR 198.8M)
* Q2 EBITDA WAS EUR 71.8M (EUR 25.3M), AN INCREASE BY
183.9%.
EBITDA MARGIN WAS 20.6% (12.7%).
* Q2 OPERATING PROFIT (EBIT) WAS EUR 46.2M (EUR -2.3M)
* WE ARE WELL AHEAD OF OUR THREE-YEAR FINANCIAL TARGETS
ENDING
2022 AND THE FINANCIAL OUTLOOK GOING FORWARD REMAINS STRONG
* WE EXPECT TO CONTINUE TO SEE A DEMAND FOR COVID-19
TESTING,
GENETIC SEQUENCING, AND PATIENT TREATMENTS HOWEVER AT LOWER
LEVELS THAN BEFORE
Source text for Eikon: ID:nWkr57lHWx
Further company coverage: MCOVb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))